Intellectual Property - February 9, 2022
Salipro Biotech receives European patent
The European Patent Office has granted a further European patent to the company, entitled “Antigen and method for production thereof”. The granted European patent follows the approval of the US-member of this patent family already in 2018 under US Patent 10,159,729 B2. “We’re excited about this important milestone that provides additional protection for our core […]
Agreement - October 12, 2021
Salipro Biotech in agreement with AbCellera
Salipro Biotech enters into a collaboration and license agreement with AbCellera for access to the Salipro platform for antibody discovery against GPCRs, ion channels, and transporters. The collaboration enables AbCellera to access Salipro Biotech’s expertise and its Salipro platform technology to generate stable antigens for challenging membrane protein drug targets for antibody discovery, the company […]
